This is an exciting initiative to commercialise the biotechnology developed by the Biopharming Research Unit at UCT. Our aim is to develop a world-class commercial-scale capability in RSA for the production of patented plant-produced enzymes, diagnostic reagents, recombinant proteins and vaccines for animal health. Presenting a viable alternative to tissue culture production. UCT is currently seeking funding to bring the first basket of products to market.